中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

50 records (took 0.037 seconds)

    Music Note Indicating Method And System For Electronic Piano, Mobile Terminal And Electronic Piano
    1.
    发明申请
    Music Note Indicating Method And System For Electronic Piano, Mobile Terminal And Electronic Piano 审中-公开
    音乐笔记电子钢琴，手机终端和电子钢琴指示方法及系统

    公开(公告)号：US20150364122A1

    公开(公告)日：2015-12-17

    申请号：US14729305

    申请日：2015-06-03

    Applicant: Bin Ye

    Inventor： Bin Ye

    IPC: G10H1/00 ,  G10C5/00

    CPC classification number: G10H1/0016 ,  G10G1/02 ,  G10H2220/061 ,  G10H2220/441 ,  G10H2240/251

    Abstract: Provided is a music note indicating method for an electronic piano, a mobile terminal, an electronic piano and a music note indicating system. The electronic piano includes a keyboard with a plurality of keys, a controlling device and a plurality of LED indicating lamps. The plurality of LED indicating lamps are located in a plane parallel to the keyboard. The method includes: obtaining a music score information of a predetermined music score by a mobile terminal; analyzing the music score information to generate a music note sequence comprising at least one first music note data by the mobile terminal; generating a control signal according to the at least one first music note data and sending the control signal to the controlling device by the mobile terminal; and controlling the plurality of LED indicating lamps to indicate the music note sequence according to the control signal by the controlling device.

    Abstract translation: 提供了一种用于电子钢琴，移动终端，电子钢琴和音乐笔记指示系统的音乐笔记指示方法。 电子钢琴包括具有多个键的键盘，控制装置和多个LED指示灯。 多个LED指示灯位于与键盘平行的平面中。 该方法包括：通过移动终端获得预定乐谱的乐谱信息; 分析音乐乐谱信息以生成由移动终端包括至少一个第一音乐数据的音乐音符序列; 根据所述至少一个第一音乐音符数据生成控制信号，并由所述移动终端向控制设备发送控制信号; 以及根据控制装置的控制信号，控制多个LED指示灯来指示音乐音符序列。

    Urinary CA125 Peptides as Biomarkers of Ovarian Cancer
    2.
    发明申请
    Urinary CA125 Peptides as Biomarkers of Ovarian Cancer 有权
    尿CA125肽作为卵巢癌生物标志物

    公开(公告)号：US20110045508A1

    公开(公告)日：2011-02-24

    申请号：US12865508

    申请日：2009-01-30

    Applicant: Bin Ye ,  Daniel Cramer

    Inventor： Bin Ye ,  Daniel Cramer

    IPC: G01N33/68 ,  C12P21/00

    CPC classification number: G01N33/57449 ,  C07K14/4748

    Abstract: The present invention is directed to diagnostic methods based upon the detection of peptides derived from the degradation of CA125. In particular, it is concerned with assays of urine samples collected from women for the purpose of determining whether they are at increased risk for having ovarian cancer, have decreased their risk as the result of clinical or non-clinical procedures, to monitor the efficacy of a treatment method, or to determine whether cancer has recurred or advanced.

    Abstract translation: 本发明涉及基于检测衍生自CA125降解的肽的诊断方法。 特别地，它涉及从妇女收集的尿液样品的测定，以确定它们是否具有增加的患有卵巢癌的风险，降低其作为临床或非临床程序的结果的风险，以监测其功效 治疗方法，或确定癌症是否复发或进展。

    RADIOGRAPHIC SYSTEM
    3.
    发明申请
    RADIOGRAPHIC SYSTEM 失效
    放射学系统

    公开(公告)号：US20080159485A1

    公开(公告)日：2008-07-03

    申请号：US11966579

    申请日：2007-12-28

    Applicant: Bin Ye

    Inventor： Bin Ye

    IPC: G03B42/04

    CPC classification number: G03B42/04

    Abstract: A radiographic system(100) is provided wherein a single X-ray detector can be handled freely using a cable and which can prevent an operator or a patient from being troubled by the cable. The radiographic system(100) comprises a radiographic panel(5) configured to radiograph in two dimensions a radiation exposed to a subject and output radiation image data, a cable(6) for the supply of electric power to the radiographic panel and transfer of the radiation image data, a conveyance unit(8) for conveying the cable in a predetermined direction, a cable length adjusting unit(7) provided in the conveyance unit to adjust the length of the cable, and a movement control unit(72) configured to move the conveyance unit in accordance with a tilting direction of the cable from the cable length adjusting unit to the radiographic panel.

    Abstract translation: 提供了一种放射线照相系统（100），其中可以使用电缆自由地处理单个X射线检测器，并且可以防止操作者或患者受到电缆的困扰。 射线照相系统（100）包括放射线照相面板（5），其配置成二维放射照射暴露于对象的辐射并输出放射线图像数据;电缆（6），用于向射线照相面板供应电力并传送 辐射图像数据，用于沿预定方向传送电缆的传送单元（8），设置在传送单元中以调节电缆长度的电缆长度调节单元（7），以及移动控制单元（72） 将输送单元按照电缆从电缆长度调节单元的倾斜方向移动到射线照相面板。

    HETEROCYCLIC PYRIDONE COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF
    10.
    发明申请
    HETEROCYCLIC PYRIDONE COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF 有权
    杂环吡啶类化合物及其中间体，制备方法及其用途

    公开(公告)号：US20140206679A1

    公开(公告)日：2014-07-24

    申请号：US14124628

    申请日：2012-05-28

    Applicant: Jianjun Cheng ,  Jihong Qin ,  Bin Ye

    Inventor： Jianjun Cheng ,  Jihong Qin ,  Bin Ye

    IPC: C07D513/04 ,  C07D498/04 ,  C07D471/04

    CPC classification number: C07D513/04 ,  C07D471/04 ,  C07D498/04

    Abstract: The present invention relates to a heterocyclic pyridone compound represented by General Formula (I), where the heterocyclic pyridone compound is used as a tyrosine kinase inhibitor, and particularly a c-Met inhibitor. The present invention also relates to intermediates for preparing heterocyclic pyridone compound and a preparation method. The present invention further relates to a pharmaceutical composition containing the heterocyclic pyridone compound as an active ingredient, and a use of the pharmaceutical composition in treatment of diseases associated with tyrosine kinase c-Met, especially cancer associated with c-Met, as a medicament.

    Abstract translation: 本发明涉及由通式（I）表示的杂环吡啶酮化合物，其中杂环吡啶酮化合物用作酪氨酸激酶抑制剂，特别是c-Met抑制剂。 本发明还涉及制备杂环吡啶酮化合物的中间体及其制备方法。 本发明还涉及含有杂环吡啶酮化合物作为活性成分的药物组合物，以及该药物组合物用于治疗与酪氨酸激酶c-Met相关疾病，特别是与c-Met相关的癌症作为药物的用途。

Patent Agency Ranking